Bicycle Therapeutics (BCYC) Other Working Capital Changes (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Other Working Capital Changes data on file, last reported at -$711000.0 in Q2 2026.

• Quarterly Other Working Capital Changes rose 47.76% year-over-year to -$711000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$4.8 million (up 7.13% YoY) and the FY2025 annual result came in at -$5.5 million, down 11.62% from the prior year.
• Other Working Capital Changes improved to -$711000.0 in Q2 2026, from -$1.3 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $89.7 million in Q3 2023 to a low of -$47.3 million in Q4 2025.
• A 5-year average of -$2.0 million and a median of -$4.1 million in 2022 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 52.72% — and 2023, when it plunged 680.9%.
• Tracing BCYC's Other Working Capital Changes over 5 years: stood at -$668000.0 in 2022, then plunged by 68.56% to -$1.1 million in 2023, then declined by 12.08% to -$1.3 million in 2024, then dropped by 11.73% to -$1.4 million in 2025, then jumped by 49.57% to -$711000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$711000.0 (Q2 2026), -$1.3 million (Q1 2026), and -$1.4 million (Q4 2025), per Business Quant data.